Publications by authors named "Jun Fukihara"

Claim this Profile
D
Desaturation in the six-minute walk test predicts progressive pulmonary fibrosis in fibrotic interstitial lung disease.
Reoto Takei, Jun Fukihara, Yasuhiko Yamano, Kensuke Kataoka, Tomoki Kimura

Respir Investig· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of booster vaccination on post-treatment oxygen deterioration in hospitalized mild-to-moderate COVID-19 Japanese patients with comorbidities during the Omicron wave.
Shunsaku Hayai, Kensuke Fukumitsu, Atsushi Suzuki, Jun Fukihara, Takuma Katano

J Infect Chemother· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Pulmonary Artery Pressure on the Response to Oxygen Administration for Exertional Desaturation in Interstitial Lung Disease.
Jun Hirasawa, Ryo Teramachi, Jun Fukihara, Fumiko Watanabe, Tomoya Ogawa

Respirology· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical significance of histological inflammation in systemic sclerosis-associated interstitial lung disease.
Shuko Hirota, Yasuhiko Yamano, Reoto Takei, Jun Fukihara, Hajime Sasano

Respir Investig· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Responsiveness and minimal clinically important difference of the COPD Assessment Test in fibrotic interstitial lung disease.
Toshiaki Matsuda, Yasuhiro Kondoh, Reoto Takei, Hajime Sasano, Jun Fukihara

Respir Investig· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Idiopathic Pulmonary Fibrosis Incidentally Detected by Computed Tomography Scan as Interstitial Lung Abnormalities.
Tomohiro Bando, Reoto Takei, Jun Fukihara, Hajime Sasano, Yasuhiko Yamano

Ann Am Thorac Soc· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitochondrial DNA in bronchoalveolar lavage fluid is associated with the prognosis of idiopathic pulmonary fibrosis: a single cohort study.
Jun Fukihara, Koji Sakamoto, Yoshiki Ikeyama, Taiki Furukawa, Ryo Teramachi

Respir Res· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of remdesivir-based therapy for moderate COVID-19: comparison of Omicron and other variant phases.
Atsushi Suzuki, Kensuke Fukumitsu, Jun Fukihara, Takuma Katano, Hisashi Kako

J Chemother· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mild elevation of pulmonary vascular resistance predicts mortality regardless of mean pulmonary artery pressure in mild interstitial lung disease.
Tomonori Sato, Taiki Furukawa, Ryo Teramachi, Jun Fukihara, Yasuhiko Yamano

Thorax· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease progression and changes in KL-6 in patients with limited cutaneous systemic sclerosis-associated interstitial lung disease.
Reoto Takei, Yasuhiko Yamano, Kensuke Kataoka, Jun Fukihara, Hajime Sasano

Respir Investig· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 and interstitial lung diseases: A multifaceted look at the relationship between the two diseases.
Jun Fukihara, Yasuhiro Kondoh

Respir Investig· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in patient-reported outcomes in patients with non-idiopathic pulmonary fibrosis fibrotic interstitial lung disease and progressive pulmonary fibrosis.
Reoto Takei, Toshiaki Matsuda, Jun Fukihara, Hajime Sasano, Yasuhiko Yamano

Front Med (Lausanne)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Experience of the Comparative Effectiveness and Safety of Molnupiravir and Nirmatrelvir/Ritonavir in High-Risk Patients with COVID-19 in a Community Setting.
Yoshikazu Mutoh, Takumi Umemura, Takeshi Nishikawa, Kaho Kondo, Yuta Nishina, Jun Fukihara

Viruses· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BMP3b Is a Novel Antifibrotic Molecule Regulated by Meflin in Lung Fibroblasts.
Atsushi Suzuki, Koji Sakamoto, Yoshio Nakahara, Atsushi Enomoto, Jun Hino, Jun Fukihara

Am J Respir Cell Mol Biol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overexpression of bone morphogenetic protein receptor type 2 suppresses transforming growth factor β-induced profibrotic responses in lung fibroblasts.
Jun Fukihara, Suzanne Maiolo, Jessica Kovac, Koji Sakamoto, Keiko Wakahara

Exp Lung Res· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19-Triggered Acute Exacerbation of IPF, an Underdiagnosed Clinical Entity With Two-Peaked Respiratory Failure: A Case Report and Literature Review.
Yosuke Goto, Koji Sakamoto, Jun Fukihara, Atsushi Suzuki, Norihito Omote

Front Med (Lausanne)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical burden of immune checkpoint inhibitor-induced pneumonitis.
Koji Sakamoto, Jun Fukihara, Masahiro Morise, Naozumi Hashimoto

Respir Investig· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute exacerbations of fibrotic interstitial lung diseases.
Atsushi Suzuki, Yasuhiro Kondoh, Kevin K Brown, Takeshi Johkoh, Kensuke Kataoka, Jun Fukihara

Respirology· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to "Prognostic Impact and Risk Factors of Immune-Related Pneumonitis in Patients With Non-Small-Cell Lung Cancer Who Received Programmed Death-1 Inhibitors".
Jun Fukihara, Koji Sakamoto, Junji Koyama, Takayasu Ito, Shingo Iwano

Clin Lung Cancer· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Probable usual interstitial pneumonia pattern on chest CT: is it sufficient for a diagnosis of idiopathic pulmonary fibrosis?
Jun Fukihara, Yasuhiro Kondoh, Kevin K Brown, Tomoki Kimura, Kensuke Kataoka

Eur Respir J· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Impact and Risk Factors of Immune-Related Pneumonitis in Patients With Non-Small-Cell Lung Cancer Who Received Programmed Death 1 Inhibitors.
Jun Fukihara, Koji Sakamoto, Junji Koyama, Takayasu Ito, Shingo Iwano

Clin Lung Cancer· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung Metastases from Bile Duct Adenocarcinoma Mimicking Chronic Airway Infection and Causing Diagnostic Difficulty.
Mitsuo Sato, Shotaro Okachi, Jun Fukihara, Yoshie Shimoyama, Keiko Wakahara

Intern Med· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hemosiderin-laden macrophages are an independent factor correlated with pulmonary vascular resistance in idiopathic pulmonary fibrosis: a case control study.
Jun Fukihara, Hiroyuki Taniguchi, Masahiko Ando, Yasuhiro Kondoh, Tomoki Kimura

BMC Pulm Med· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nintedanib (OFEV) in the treatment of idiopathic pulmonary fibrosis.
Jun Fukihara, Yasuhiro Kondoh

Expert Rev Respir Med· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary hypertension associated with obliterative phlebitis in IgG4-related lung disease.
Jun Fukihara, Yasuhiro Kondoh, Hiroyuki Taniguchi, Tomoki Kimura, Kensuke Kataoka

Eur Respir J· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis